Egyptian Hypertrophic Cardiomyopathy Program
ConditionHypertrophic Cardiomyopathy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMagdi Yacoub Heart Foundation
About this trial
Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.
Eligibility criteria
Qualifiers
All patients diagnosed with hypertrophic cardiomyopathy (index patients) who are willing and consented to participate in the registry.
All family members of index patients who are willing and consented to participate in the registry.
Disqualifiers
Refusal to consent to participate in the registry program.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov